In addition, Stattic treatment abolished rhG-CSF-mediated upregulation of mesenchymal markers at both protein and mRNA levels (Figure 6D and E), indicating that G-CSF/Stat3 signaling is able to promote EMT of breast cancer cells. This evidence concerns the gene STAT3 and breast carcinoma.